News and Comments

The Sky’s The Limit For Micromet’s BiTE Technology’s Capability

  Tuesday, July 19, 2011

Micromet (MITI) added another important collaborator, Amgen (AMGN), to a long list of large and small drug developing companies that are attracted to Micromet’s BiTE technology. Amgen/Micromet agreement looks fair for both. It fits Amgen’s strategy of focusing on adding next-generation products to its pipeline and helps Micromet’s financial requirements during the development of its promising proprietary cancer programs. Amgen wanted to select from among three BiTE-based drugs against three undisclosed solid tumor targets. The giant biotech will pay upfront, milestone, and other payments in a deal that could be worth over $900 million for the two selected drugs, or half of this amount if it selects only one drug, in addition to double-digit royalties in the event of approvals and sales. More...

Recent Postings



Velcade (bortezomib) Seattle Genetics (SGEN) Multiple Myeloma Exelixis (EXEL) Agenus (AGEN Roche (ROCHE) Zerenex Endometrial Cancer Regeneron (REGN) Sanofi-Aventis (SAN) ABBVIE (ABBV) Incyte (INCY) Prosensa (RNA) Sanofi (SNA) galapagos (GLPG) Aimmune Therapeutics (AIMT) ImmunoGen (IMGN) Sanofi (SNY) VANDA (VNDA) Galena (GALE) Cytokinetics (CYTK) Bristol-Myers Squibb (BMY) Benlysta (belimumab) Theravance Bio Pharma (TBPH) Dendreon (DNDN) Merck (MRK) SYNTA (SNTA) Alder Biopharmaceuticals (ALDR) GUARDIAN HEALTH Alnylam (ALNY) NANTKWEST (NK) Ariad (ARIA) Mirati Therapeutics (MRTX) Dynavax (DVAX) Anadys (ANDS) JUNO (JUNO) Intermune (ITMN) REGULUS (RGLS) ADVENTRIX (ANX) TOKAI (TKAOI) Auspex (ASPX) Onyx (ONXX) Trastuzumab-DM1 Tysabri C4 Therapeutics Illumina (ILMN) Abbott Laboratories (ABT) SUNESIS PHARMACEUTICALS (SNSS) Array Pharmaceuticals (ARRY) Roche (RHHBY) Anacor (ANAC) KERYX (KERX) ACADIA (ACAD) Biocryst (BCRX) Human Longevity (HLI) KITE (KITE) Jazz Pharmaceuticals (JAZZ) Amgen (AMGN) Idenix (IDIX) Gilead (GILD) Elan (ELN) Revlimid (lenolidamide) CompuGen (CGEN) Xoma (XOMA) Genentech Ziofpharm (ZIOP) Pluristem (PSTI) SERES THERAPEUTICS (MCRB) NEKTAR (NKTR)) AERIE PHARMACEUTICALS Agenus (AGEN) ISIS (ISIS) Human Genome Sciences (HGSI) ARCA (ABIO) Theravance (THRX) Sequenom (SQNM) Vitae Pharmaceuticals (VTAE) Valeant Pharmaceuticals International (VRX) Biogen Idec (BIIB) BIOMARIN (BMRN) Intercept (ICPT) Herceptin Prolor Biotech (PBTH) Sangamo (SGMO) HALOZYME (HALO) Vertex (VRTX) Ridaforolimus Intrexon (XON) Telaprevir Rapamune IDERA (IDRA) Inovio (INO) GlaxoSmithKline (GSK) Ionis (IONS) OSI (OSIP) ZALTRAP™ Sarepta (SRPT) Micromet (MITI)